Most Antiretrovirals Covered by Medicare Part D (as of 2017) Are Brand-Name, Single Source Medications
Most ARVs Covered by Medicare Part D are Brand Single Source Download
Search
-
-
Poll: On Health Care, Democrats and Democratic-Leaning Independents Trust Sen. Sanders the Most, but Significantly More People Support a Public Option than Medicare-for-All
News Release3 in 4 Americans Do Not Expect Congress to Take Action to Lower Drug Costs Before the 2020 Election Ahead of tonight’s Democratic presidential debate, Sen. Bernie Sanders is the candidate most trusted on health care by Democrats and Democratic-leaning independents, though the Medicare-for-all plan he has championed is significantly less popular than the “public option” approach put forward by some other candidates, the latest KFF Health Tracking Poll finds. Among the overall public, a…
-
KFF Health Tracking Poll – Early April 2020: The Impact Of Coronavirus On Life In America
ReportFielded from March 25-30, this poll tracks how the rapidly unfolding coronavirus (COVID19) pandemic is affecting Americans, including health and economic impacts to date and worries about the future. This poll also examines the implications of the pandemic on the 2020 presidential election, including favorability of the ACA, Medicare-for-all and a public option.
-
Key Facts about Uninsured Adults with Opioid Use Disorder
Issue BriefThis data note describes uninsured nonelderly adults with opioid use disorder, including their demographic characteristics, health status, and access to treatment.
-
List Prices Increased As Much As 9 Times Faster Than Inflation for 20 of the Top 25 Part D Drugs, Suggesting Potential for Savings Under Proposed Inflation Rebate Policies
News ReleaseA new KFF analysis finds that the list prices for most of the top Medicare Part D drugs by total spending increased as much as nine times the rate of inflation (1.7%) between 2016 and 2017, suggesting recent Congressional proposals targeting such increases could generate savings for Medicare and Part D enrollees. The analysis finds 20 of the top 25 drugs, all of which were brand-name medications, had price increases between three and more than…
-
The Effects of Medicaid Expansion under the ACA: Studies from January 2014 to January 2020
ReportThis literature review summarizes findings from 404 studies of the impact of state Medicaid expansions under the ACA published between January 2014 (when the coverage provisions of the ACA went into effect) and January 2020. It includes studies, analyses, and reports published by government, research, and policy organizations using data from 2014 or later. This body of research suggests that the expansion presents an opportunity for gains in coverage, improvements in access and financial security,…
-
How Can Medicaid Enhance State Capacity to Respond to COVID-19?
Issue BriefThis brief describes a range of steps states and the federal government could take to use Medicaid to expand coverage and access to care in the context of responding to COVID-19 as a public health crisis.
-
Kaiser Health News (KHN) announces a new partnership with An Arm and A Leg podcast
News ReleaseKFF and Public Road Productions announce that Season 2 of An Arm and A Leg podcast will be co-produced in partnership with Kaiser Health News (KHN), KFF’s editorially independent national health and health policy newsroom.
-
Loss of the ACA Could Greatly Erode Health Coverage and Benefits for Women
Issue BriefThis brief examines what the loss of the Affordable Care Act (ACA) would mean for women's coverage and access to health care.
-
HIV, Intimate Partner Violence (IPV), and Women: An Emerging Policy Landscape
Issue BriefIntimate partner violence has been shown to be associated with increased risk for HIV among women, as well as poorer treatment outcomes for those already diagnosed. This brief reviews the link between IPV and HIV, key policy changes and initiatives that attempt to address these challenges.